Shree Hari International Llc Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Shree Hari International Llc Pharmaceutical Import Records from India — 6 Products, $5.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Shree Hari International Llc — Pharmaceutical Importer Profile (2026) | 6 Products, $5.2M Trade | TransData Nexus

Shree Hari International Llc

Pharmaceutical Importer · United States · Analgesics & Antipyretics Focus · $5.2M Total Trade · DGFT Verified

Shree Hari International Llc is a pharmaceutical importer based in United States with a total trade value of $5.2M across 6 products in 5 therapeutic categories. Based on 150 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Shree Hari International Llc sources from 2 verified Indian suppliers, with Elysium Pharmaceuticals Limited accounting for 99.9% of imports.

Shree Hari International Llc — Import Portfolio & Supplier Network

Shree Hari International Llc import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Shree Hari International Llc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Elysium Pharmaceuticals Limited	$3.6M	151	99.9%
Apnar Pharma Private Limited	$3.9K	4	0.1%

Shree Hari International Llc sources from 2 verified Indian suppliers across 76 distinct formulations.

What Formulations Does Shree Hari International Llc Import?

Formulation	Value	Ships
Acetaminophen guaifenesin dextromethorphen hydrobromide and phenylephrine hcl capsules-913 (annexure-a) as per	$417.3K	12
Acetaminophen dextromethorphen hydrobromide,doxylamine succinate & phenylephrine hcl capsules-907(annexure-b) as per	$260.7K	6
Folic acid tablets USP 1MG (annexure - a) as per	$144.2K	3
Diphenhydramine hcl 25MG tablets s-4 (pink) (annexure - b) as per	$111.6K	6
Acetaminophen TAB's USP 500MG (s500) (annexure-a) as per	$100.0K	2
Guaifenesin tablets USP 400MG (annexure-e) as per	$93.0K	6
Acetaminophen TAB's USP 325MG (annexure- f) as per	$75.4K	6
Phenylephrine hydrochloride tablets usp10mg (annexure-g) as per	$74.6K	6
Sennosides tablets USP 8.6MG (annexure-b) (other as per inv & plist)	$63.7K	2
Sennosides tablets USP 8.6MG (annexure - b) as per	$57.9K	4
Labetalol hydrochloride tabs USP 100 MG	$50.0K	1
Labetalol hydrochloride tabs USP 200 MG	$50.0K	1
Folic acid tablets USP 1MG (annexure-a)	$50.0K	1
Folic acid tablets USP 1MG annexure -	$50.0K	1
Acetaminophen aspirin and caffeine	$50.0K	1

Shree Hari International Llc imports 76 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Acetaminophen	Analgesics & Antipyretics	$2.6M	69	1.1%	10
2	Phenylephrine	Respiratory & OTC	$1.1M	30	1.3%	17
3	Guaifenesin	Respiratory & OTC	$665.9K	24	2.5%	8
4	Folic	Nutritional Supplements	$400.0K	8	0.7%	11
5	Diphenhydramine	Antihistamines & Allergy	$333.0K	15	1.0%	14
6	Docusate	Gastrointestinal	$89.5K	4	1.0%	14

Shree Hari International Llc imports 6 pharmaceutical products across 5 categories into United States totaling $5.2M.

Shree Hari International Llc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Shree Hari International LLC is a U.S.-based pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from India. Operating as a buyer, the company plays a pivotal role in sourcing and distributing a diverse range of pharmaceutical products within the United States market. Headquartered in East Brunswick, New Jersey, Shree Hari International LLC is an independent entity without a publicly known parent company. Its primary function involves importing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, thereby contributing to the availability of various therapeutic options in the U.S.

2Distribution Network

While specific details about Shree Hari International LLC's warehouse locations and logistics capabilities are not publicly disclosed, the company's operations suggest a well-established distribution network within the United States. The importation of pharmaceutical products from India indicates a reliance on efficient logistics to manage the complexities of international shipping, customs clearance, and compliance with U.S. regulations. The company's geographic coverage likely spans key U.S. regions, ensuring timely delivery to meet market demand.

3Industry Role

In the U.S. pharmaceutical supply chain, Shree Hari International LLC functions as a pharmaceutical importer, sourcing finished pharmaceutical formulations from Indian manufacturers. By facilitating the entry of these products into the U.S. market, the company serves as a critical intermediary between Indian pharmaceutical producers and U.S. distributors, wholesalers, and healthcare providers. This role is essential in diversifying the pharmaceutical supply and providing access to a broader range of medications.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Shree Hari International Llc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Shree Hari International LLC's sourcing strategy exhibits a high degree of concentration, with a significant majority of its imports originating from Elysium Pharmaceuticals Limited. This single-source dependency may present risks, such as supply chain disruptions due to geopolitical events, regulatory changes, or operational issues within the supplier's facilities. However, the company's extensive history of 151 shipments with Elysium Pharmaceuticals Limited suggests a stable and reliable relationship, potentially mitigating some of these risks. The minimal engagement with other suppliers indicates a strategic choice to maintain consistency and quality in its product offerings.

2Supply Chain Resilience

The resilience of Shree Hari International LLC's supply chain is closely tied to the stability and reliability of Elysium Pharmaceuticals Limited. The company's limited number of suppliers and formulations imported suggests a focused approach, which can streamline operations but may also expose the company to risks if alternative suppliers are not readily available. The reliance on a single supplier necessitates a thorough assessment of Elysium Pharmaceuticals Limited's manufacturing capabilities, financial health, and compliance with international quality standards to ensure uninterrupted supply.

Strategic Implications

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The Federal Food, Drug, and Cosmetic Act (FD&C Act) provides the legal framework governing these activities, ensuring that imported drugs meet standards for safety, efficacy, and quality. The FDA's regulations require that all drugs offered for importation into the U.S. comply with specific labeling, manufacturing, and testing standards to protect public health.

2Import Licensing & GMP

Importers of pharmaceutical products into the United States must adhere to FDA regulations, which include obtaining appropriate import licenses and ensuring that imported drugs are manufactured in facilities compliant with Good Manufacturing Practice (GMP) standards. The FDA recognizes GMP certifications from various international bodies, including the European Union (EU) GMP, World Health Organization (WHO) GMP, and Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications are essential for ensuring that imported pharmaceutical products meet the required quality standards.

3Quality & Labeling

Shree Hari International Llc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Shree Hari International LLC's focus on importing analgesics, antipyretics, respiratory over-the-counter (OTC) medications, and nutritional supplements aligns with prevalent health concerns and consumer demand in the United States. The substantial import value of acetaminophen and phenylephrine indicates a strategic emphasis on products with consistent market demand. This product mix suggests a targeted approach to address common health issues, positioning the company to meet the needs of a broad consumer base.

2Sourcing Profile

The company's sourcing strategy centers on generic drug formulations, primarily sourced from India, which is recognized as a major global supplier of affordable pharmaceuticals. By focusing on finished formulations, Shree Hari International LLC ensures that imported products are ready for distribution, streamlining the supply chain and reducing time to market. This approach leverages India's manufacturing capabilities and cost advantages, aligning with the company's objectives to provide cost-effective pharmaceutical options to the U.S. market.

3Market Positioning

Seller's Guide — How to Become a Supplier to Shree Hari International Llc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Shree Hari International LLC, particularly those capable of meeting the company's quality standards and regulatory requirements. The company's limited number of suppliers suggests potential gaps in its current sourcing strategy, which new entrants could fill by offering competitive pricing, reliable supply chains, and compliance with FDA regulations. Establishing partnerships with Shree Hari International LLC could provide Indian exporters with access to the U.S. market, leveraging the company's established distribution channels and market knowledge.

2Requirements & Qualifications

Indian exporters seeking to supply Shree Hari International LLC must ensure that their products are manufactured in facilities compliant with recognized GMP standards, such as EU GMP, WHO GMP, or PIC/S certifications. Products must undergo batch testing and stability studies to meet FDA requirements. Additionally, labeling must be informative, truthful, and in English, adhering to FDA regulations. Compliance with these standards is essential for establishing a successful partnership and ensuring the acceptance of products into the U.S. market.

How to Approach

Frequently Asked Questions — Shree Hari International Llc

What products does Shree Hari International Llc import from India?

Shree Hari International Llc imports 6 pharmaceutical products across 5 categories. Top imports: Acetaminophen ($2.6M), Phenylephrine ($1.1M), Guaifenesin ($665.9K), Folic ($400.0K), Diphenhydramine ($333.0K).

Who supplies pharmaceuticals to Shree Hari International Llc from India?

Shree Hari International Llc sources from 2 verified Indian suppliers. The primary supplier is Elysium Pharmaceuticals Limited (99.9% of imports, $3.6M).

What is Shree Hari International Llc's total pharmaceutical import value?

Shree Hari International Llc's total pharmaceutical import value from India is $5.2M, based on 150 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Shree Hari International Llc focus on?

Shree Hari International Llc imports across 5 categories. The largest: Analgesics & Antipyretics (50.5%), Respiratory & OTC (33.8%), Nutritional Supplements (7.7%).

Get Full Shree Hari International Llc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.